Researcher Maureen Ferran featured in Rochester First article
Photodynamic Therapy research group is looking at ways to beat cancer
Maureen, associate professor of biology in the College of Science, and team are using a new light therapy treatment called photosensitizer against the human papillomavirus (HPV). Access the Full Article here
Recommended News
-
February 23, 2023
![researcher writing with a marker on a clear surface toward the camera.]()
Funding for RIT research tops $92 million
Rochester Beacon highlights RIT’s research portfolio.
-
August 4, 2022
![two syringes and a small glass vial of smallpox and moneypox vaccine.]()
Monkeypox vaccines: A virologist answers 6 questions about how they work, who can get them and how well they prevent infection
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the two vaccines that can protect against monkeypox.
-
March 28, 2022
![professor and students watching another student use a pipette.]()
RIT scientist receives NIH grant to study viruses with potential to treat prostate cancer
The National Institutes of Health are funding RIT scientists to explore vesicular stomatitis virus’s (VSV) potential for treating prostate cancer. Associate Professor Maureen Ferran from the Thomas H. Gosnell School of Life Sciences secured a three-year, $451,718 Research Enhancement Award (R15) grant from the NIH to investigate prostate cancer cells’ susceptibility to the virus.
-
January 19, 2022
![illustration of several hands administering vaccines to the continents.]()
CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally
Essay by Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, published by The Conversation.
